← Leaderboards
Delaney Kate Geitgey
Emory University
$120,786
Attributed
$120,786
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $71.8K · FY2024–25$100K$75K$50K$25K$0
'24
'25
Funding mix
By agency
NIH$120,786 · 2
By mechanism
F31$69,748 · 1
F99$51,038 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Brian D. Evavold$24,193,113
- Khalid S. Salaita$12,706,564
- Gregory B. Lesinski$9,344,242
- Kyle C McKenna$2,205,573
- Douglas C Wallace$28,541,550
Others in their field
Other Rising Stars on “Immunotherapy”
- Sabrina Paganoni · Massachusetts General Hospital$11,004,714
- Suma Babu · Massachusetts General Hospital$11,004,714
- Yicheng Wang · Immunova Therapeutics, Llc$4,000,000
- Weston Daniel · Evoq Therapeutics, Inc.$3,507,243
- Yuwen Zhu · University Of Colorado Denver$3,496,594
- Dmitriy Zamarin · Sloan-Kettering Inst Can Research$3,427,557
Research focus
ImmunotherapyInnovationFightingImmunocompetentDesmoplasticInhibitorDipeptidyl-Peptidase IvEngineeringImmuneImmune SystemAdoptive Cell TransfersCytokineCancer ImmunotherapyImproved OutcomeCongenicCar T Cell TherapyEfficacy EvaluationCd4 Positive T LymphocytesCd8b1 GeneChimeric Antigen ReceptorChimeric Antigen Receptor T CellsCellsCell TherapyIn Vivo
Grant awards (3)
Engineering CD4+ T cells to develop a novel immunotherapy for pancreatic cancer$51,038
F99 · FY2025 · CA · contact PI
Engineering CD4+ T cells to develop a novel immunotherapy for pancreatic cancer$20,774
F31 · FY2025 · CA · contact PI
Engineering CD4+ T cells to develop a novel immunotherapy for pancreatic cancer$48,974
F31 · FY2024 · CA · contact PI